Global Generic Medicine Market Research Report 2022

Global Generic Medicine Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.2.5 By Application:
1.2.6 CNS
1.2.7 Cardiovascular
1.2.8 Respiratory
1.2.9 Rheumatology
1.2.10 Diabetes
1.2.11 Oncology
1.3 Market by Application
1.3.1 Global Generic Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Medicine Market Perspective (2017-2028)
2.2 Generic Medicine Growth Trends by Region
2.2.1 Generic Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Generic Medicine Historic Market Size by Region (2017-2022)
2.2.3 Generic Medicine Forecasted Market Size by Region (2023-2028)
2.3 Generic Medicine Market Dynamics
2.3.1 Generic Medicine Industry Trends
2.3.2 Generic Medicine Market Drivers
2.3.3 Generic Medicine Market Challenges
2.3.4 Generic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Medicine Players by Revenue
3.1.1 Global Top Generic Medicine Players by Revenue (2017-2022)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Medicine Revenue
3.4 Global Generic Medicine Market Concentration Ratio
3.4.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2021
3.5 Generic Medicine Key Players Head office and Area Served
3.6 Key Players Generic Medicine Product Solution and Service
3.7 Date of Enter into Generic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Medicine Breakdown Data by Type
4.1 Global Generic Medicine Historic Market Size by Type (2017-2022)
4.2 Global Generic Medicine Forecasted Market Size by Type (2023-2028)
5 Generic Medicine Breakdown Data by Application
5.1 Global Generic Medicine Historic Market Size by Application (2017-2022)
5.2 Global Generic Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Generic Medicine Market Size (2017-2028)
6.2 North America Generic Medicine Market Size by Country (2017-2022)
6.3 North America Generic Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Generic Medicine Market Size (2017-2028)
7.2 Europe Generic Medicine Market Size by Country (2017-2022)
7.3 Europe Generic Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Medicine Market Size (2017-2028)
8.2 Asia-Pacific Generic Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Generic Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Generic Medicine Market Size (2017-2028)
9.2 Latin America Generic Medicine Market Size by Country (2017-2022)
9.3 Latin America Generic Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Medicine Market Size (2017-2028)
10.2 Middle East & Africa Generic Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Generic Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Generic Medicine Introduction
11.1.4 Teva Revenue in Generic Medicine Business (2017-2022)
11.1.5 Teva Recent Development
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Detail
11.2.2 Novartis - Sandoz Business Overview
11.2.3 Novartis - Sandoz Generic Medicine Introduction
11.2.4 Novartis - Sandoz Revenue in Generic Medicine Business (2017-2022)
11.2.5 Novartis - Sandoz Recent Development
11.3 Mylan
11.3.1 Mylan Company Detail
11.3.2 Mylan Business Overview
11.3.3 Mylan Generic Medicine Introduction
11.3.4 Mylan Revenue in Generic Medicine Business (2017-2022)
11.3.5 Mylan Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Detail
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Medicine Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2017-2022)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Aspen
11.5.1 Aspen Company Detail
11.5.2 Aspen Business Overview
11.5.3 Aspen Generic Medicine Introduction
11.5.4 Aspen Revenue in Generic Medicine Business (2017-2022)
11.5.5 Aspen Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Detail
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Medicine Introduction
11.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2017-2022)
11.6.5 Fresenius Kabi Recent Development
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Detail
11.7.2 Pfizer (Hospira) Business Overview
11.7.3 Pfizer (Hospira) Generic Medicine Introduction
11.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2017-2022)
11.7.5 Pfizer (Hospira) Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Generic Medicine Introduction
11.8.4 Sanofi Revenue in Generic Medicine Business (2017-2022)
11.8.5 Sanofi Recent Development
11.9 Aurobindo
11.9.1 Aurobindo Company Detail
11.9.2 Aurobindo Business Overview
11.9.3 Aurobindo Generic Medicine Introduction
11.9.4 Aurobindo Revenue in Generic Medicine Business (2017-2022)
11.9.5 Aurobindo Recent Development
11.10 Lupin
11.10.1 Lupin Company Detail
11.10.2 Lupin Business Overview
11.10.3 Lupin Generic Medicine Introduction
11.10.4 Lupin Revenue in Generic Medicine Business (2017-2022)
11.10.5 Lupin Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Detail
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Generic Medicine Introduction
11.11.4 Dr. Reddy's Revenue in Generic Medicine Business (2017-2022)
11.11.5 Dr. Reddy's Recent Development
11.12 Apotex
11.12.1 Apotex Company Detail
11.12.2 Apotex Business Overview
11.12.3 Apotex Generic Medicine Introduction
11.12.4 Apotex Revenue in Generic Medicine Business (2017-2022)
11.12.5 Apotex Recent Development
11.13 Cipla
11.13.1 Cipla Company Detail
11.13.2 Cipla Business Overview
11.13.3 Cipla Generic Medicine Introduction
11.13.4 Cipla Revenue in Generic Medicine Business (2017-2022)
11.13.5 Cipla Recent Development
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Detail
11.14.2 ENDO (Par Pharmaceutical) Business Overview
11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction
11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2017-2022)
11.14.5 ENDO (Par Pharmaceutical) Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Detail
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Generic Medicine Introduction
11.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2017-2022)
11.15.5 Stada Arzneimittel Recent Development
11.16 Krka Group
11.16.1 Krka Group Company Detail
11.16.2 Krka Group Business Overview
11.16.3 Krka Group Generic Medicine Introduction
11.16.4 Krka Group Revenue in Generic Medicine Business (2017-2022)
11.16.5 Krka Group Recent Development
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Detail
11.17.2 Nichi-Iko Pharmaceutical Business Overview
11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction
11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2017-2022)
11.17.5 Nichi-Iko Pharmaceutical Recent Development
11.18 Valeant
11.18.1 Valeant Company Detail
11.18.2 Valeant Business Overview
11.18.3 Valeant Generic Medicine Introduction
11.18.4 Valeant Revenue in Generic Medicine Business (2017-2022)
11.18.5 Valeant Recent Development
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Detail
11.19.2 Zydus Cadila Business Overview
11.19.3 Zydus Cadila Generic Medicine Introduction
11.19.4 Zydus Cadila Revenue in Generic Medicine Business (2017-2022)
11.19.5 Zydus Cadila Recent Development
11.20 Hikma
11.20.1 Hikma Company Detail
11.20.2 Hikma Business Overview
11.20.3 Hikma Generic Medicine Introduction
11.20.4 Hikma Revenue in Generic Medicine Business (2017-2022)
11.20.5 Hikma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Generic Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Simple Generic Drugs
Table 3. Key Players of Super Generic Drugs
Table 4. Key Players of Biosimilars
Table 5. Key Players of By Application:
Table 6. Key Players of CNS
Table 7. Key Players of Cardiovascular
Table 8. Key Players of Respiratory
Table 9. Key Players of Rheumatology
Table 10. Key Players of Diabetes
Table 11. Key Players of Oncology
Table 12. Global Generic Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Generic Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Generic Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Generic Medicine Market Share by Region (2017-2022)
Table 16. Global Generic Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Generic Medicine Market Share by Region (2023-2028)
Table 18. Generic Medicine Market Trends
Table 19. Generic Medicine Market Drivers
Table 20. Generic Medicine Market Challenges
Table 21. Generic Medicine Market Restraints
Table 22. Global Generic Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Generic Medicine Market Share by Players (2017-2022)
Table 24. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Medicine as of 2021)
Table 25. Ranking of Global Top Generic Medicine Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Generic Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Generic Medicine Product Solution and Service
Table 29. Date of Enter into Generic Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Generic Medicine Revenue Market Share by Type (2017-2022)
Table 33. Global Generic Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Generic Medicine Revenue Market Share by Type (2023-2028)
Table 35. Global Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Generic Medicine Revenue Market Share by Application (2017-2022)
Table 37. Global Generic Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Generic Medicine Revenue Market Share by Application (2023-2028)
Table 39. North America Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia-Pacific Generic Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 44. Asia-Pacific Generic Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 45. Latin America Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 46. Latin America Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 47. Middle East & Africa Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 48. Middle East & Africa Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 49. Teva Company Detail
Table 50. Teva Business Overview
Table 51. Teva Generic Medicine Product
Table 52. Teva Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 53. Teva Recent Development
Table 54. Novartis - Sandoz Company Detail
Table 55. Novartis - Sandoz Business Overview
Table 56. Novartis - Sandoz Generic Medicine Product
Table 57. Novartis - Sandoz Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 58. Novartis - Sandoz Recent Development
Table 59. Mylan Company Detail
Table 60. Mylan Business Overview
Table 61. Mylan Generic Medicine Product
Table 62. Mylan Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 63. Mylan Recent Development
Table 64. Sun Pharmaceutical Company Detail
Table 65. Sun Pharmaceutical Business Overview
Table 66. Sun Pharmaceutical Generic Medicine Product
Table 67. Sun Pharmaceutical Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 68. Sun Pharmaceutical Recent Development
Table 69. Aspen Company Detail
Table 70. Aspen Business Overview
Table 71. Aspen Generic Medicine Product
Table 72. Aspen Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 73. Aspen Recent Development
Table 74. Fresenius Kabi Company Detail
Table 75. Fresenius Kabi Business Overview
Table 76. Fresenius Kabi Generic Medicine Product
Table 77. Fresenius Kabi Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 78. Fresenius Kabi Recent Development
Table 79. Pfizer (Hospira) Company Detail
Table 80. Pfizer (Hospira) Business Overview
Table 81. Pfizer (Hospira) Generic Medicine Product
Table 82. Pfizer (Hospira) Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 83. Pfizer (Hospira) Recent Development
Table 84. Sanofi Company Detail
Table 85. Sanofi Business Overview
Table 86. Sanofi Generic Medicine Product
Table 87. Sanofi Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. Aurobindo Company Detail
Table 90. Aurobindo Business Overview
Table 91. Aurobindo Generic Medicine Product
Table 92. Aurobindo Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 93. Aurobindo Recent Development
Table 94. Lupin Company Detail
Table 95. Lupin Business Overview
Table 96. Lupin Generic Medicine Product
Table 97. Lupin Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 98. Lupin Recent Development
Table 99. Dr. Reddy's Company Detail
Table 100. Dr. Reddy's Business Overview
Table 101. Dr. Reddy's Generic MedicineProduct
Table 102. Dr. Reddy's Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 103. Dr. Reddy's Recent Development
Table 104. Apotex Company Detail
Table 105. Apotex Business Overview
Table 106. Apotex Generic MedicineProduct
Table 107. Apotex Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 108. Apotex Recent Development
Table 109. Cipla Company Detail
Table 110. Cipla Business Overview
Table 111. Cipla Generic MedicineProduct
Table 112. Cipla Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 113. Cipla Recent Development
Table 114. ENDO (Par Pharmaceutical) Company Detail
Table 115. ENDO (Par Pharmaceutical) Business Overview
Table 116. ENDO (Par Pharmaceutical) Generic MedicineProduct
Table 117. ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 118. ENDO (Par Pharmaceutical) Recent Development
Table 119. Stada Arzneimittel Company Detail
Table 120. Stada Arzneimittel Business Overview
Table 121. Stada Arzneimittel Generic MedicineProduct
Table 122. Stada Arzneimittel Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 123. Stada Arzneimittel Recent Development
Table 124. Krka Group Company Detail
Table 125. Krka Group Business Overview
Table 126. Krka Group Generic MedicineProduct
Table 127. Krka Group Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 128. Krka Group Recent Development
Table 129. Nichi-Iko Pharmaceutical Company Detail
Table 130. Nichi-Iko Pharmaceutical Business Overview
Table 131. Nichi-Iko Pharmaceutical Generic MedicineProduct
Table 132. Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 133. Nichi-Iko Pharmaceutical Recent Development
Table 134. Valeant Company Detail
Table 135. Valeant Business Overview
Table 136. Valeant Generic MedicineProduct
Table 137. Valeant Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 138. Valeant Recent Development
Table 139. Zydus Cadila Company Detail
Table 140. Zydus Cadila Business Overview
Table 141. Zydus Cadila Generic MedicineProduct
Table 142. Zydus Cadila Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 143. Zydus Cadila Recent Development
Table 144. Hikma Company Detail
Table 145. Hikma Business Overview
Table 146. Hikma Generic MedicineProduct
Table 147. Hikma Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 148. Hikma Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Medicine Market Share by Type: 2021 VS 2028
Figure 2. Simple Generic Drugs Features
Figure 3. Super Generic Drugs Features
Figure 4. Biosimilars Features
Figure 5. By Application: Features
Figure 6. CNS Features
Figure 7. Cardiovascular Features
Figure 8. Respiratory Features
Figure 9. Rheumatology Features
Figure 10. Diabetes Features
Figure 11. Oncology Features
Figure 12. Global Generic Medicine Market Share by Application in 2021 & 2028
Figure 13. CNS Case Studies
Figure 14. Cardiovascular Case Studies
Figure 15. Respiratory Case Studies
Figure 16. Rheumatology Case Studies
Figure 17. Diabetes Case Studies
Figure 18. Oncology Case Studies
Figure 19. Others Case Studies
Figure 20. Generic Medicine Report Years Considered
Figure 21. Global Generic Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 22. Global Generic Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 23. Global Generic Medicine Market Share by Region: 2021 VS 2028
Figure 24. Global Generic Medicine Market Share by Players in 2021
Figure 25. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Medicine as of 2021)
Figure 26. The Top 10 and 5 Players Market Share by Generic Medicine Revenue in 2021
Figure 27. North America Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. North America Generic Medicine Market Share by Country (2017-2028)
Figure 29. United States Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Canada Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Europe Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Europe Generic Medicine Market Share by Country (2017-2028)
Figure 33. Germany Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. France Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. U.K. Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Italy Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Russia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Nordic Countries Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Asia-Pacific Generic Medicine Market Share by Region (2017-2028)
Figure 41. China Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Latin America Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Latin America Generic Medicine Market Share by Country (2017-2028)
Figure 49. Mexico Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Generic Medicine Market Share by Country (2017-2028)
Figure 53. Turkey Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Teva Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 56. Novartis - Sandoz Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 57. Mylan Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 58. Sun Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 59. Aspen Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 60. Fresenius Kabi Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 61. Pfizer (Hospira) Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 63. Aurobindo Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 64. Lupin Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 65. Dr. Reddy's Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 66. Apotex Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 67. Cipla Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 68. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 69. Stada Arzneimittel Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 70. Krka Group Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 71. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 72. Valeant Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 73. Zydus Cadila Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 74. Hikma Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs